Clinical Trial

Lithium for Fracture Treatment

Study Description

Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)

This is a study designed to see if a low dose of Lithium treatment, taken for 2 weeks, can improve fracture healing and improve patients' function and productivity.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Lithium Carbonate

Intervention begins 14 days after injury for non-surgical participants and 2 weeks after surgery for participants who have surgical treatment of their fractures.

Drug - Lactose Placebo

Intervention begins 14 days after injury for non-surgical participants and 2 weeks after surgery for participants who have surgical treatment of their fractures.

Additional Information

Official Study Title

Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial

Clinical Trial ID

NCT02999022

ParticipAid ID

Yer64e